ArticleRespirology (Carlton, Vic.)2023

Mepolizumab attenuates ILC2s proliferation and activity in adults with severe eosinophilic asthma.

Guy Brusselle et al.PubMed ↗Publisher ↗

No numbers read from the abstract.